0001400482-17-000013.txt : 20170203
0001400482-17-000013.hdr.sgml : 20170203
20170203154711
ACCESSION NUMBER: 0001400482-17-000013
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170202
FILED AS OF DATE: 20170203
DATE AS OF CHANGE: 20170203
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: KUBOTA PHARMACEUTICAL HOLDINGS CO LTD
CENTRAL INDEX KEY: 0001400482
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981295657
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4-20-3 EBISU
STREET 2: SHIBUYA-KU
CITY: TOKYO
STATE: M0
ZIP: 150-0013
BUSINESS PHONE: 81 3 5789-5872
MAIL ADDRESS:
STREET 1: 4-20-3 EBISU
STREET 2: SHIBUYA-KU
CITY: TOKYO
STATE: M0
ZIP: 150-0013
FORMER COMPANY:
FORMER CONFORMED NAME: ACUCELA INC.
DATE OF NAME CHANGE: 20131217
FORMER COMPANY:
FORMER CONFORMED NAME: Acucela Inc
DATE OF NAME CHANGE: 20070523
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: DANSE EDWARD H
CENTRAL INDEX KEY: 0001016353
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-55133
FILM NUMBER: 17571976
MAIL ADDRESS:
STREET 1: 2525 DUPONT DRIVE
CITY: IRVINE
STATE: CA
ZIP: 92715
4
1
wf-form4_148615481841842.xml
FORM 4
X0306
4
2017-02-02
0
0001400482
KUBOTA PHARMACEUTICAL HOLDINGS CO LTD
M??????
0001016353
DANSE EDWARD H
C/O ACUCELA INC.
1301 2ND AVE., SUITE 4200
SEATTLE
WA
98101
0
1
0
0
Chief Business Officer
Common Stock
2017-02-02
4
S
0
1250
8.50
D
74664
D
On November 30, 2016, the issuer completed its change in place of incorporation, pursuant to which Kubota Pharmaceutical Holdings Co., Ltd., a Japanese corporation ("Kubota Holdings"), became the publicly traded parent company of the Kubota group of companies. Each issued and outstanding share of common stock of Acucela Inc., a Washington corporation ("Acucela US"), was cancelled and converted into one share of common stock of Kubota Holdings. Pursuant to Rule 12g-3(a) under the Securities Exchange Act of 1934, as amended, Kubota Holdings is the successor issuer to Acucela US.
The issuer's common stock trades on the Tokyo Stock Exchange under the code 4596.
The sale on this Form 4 was effected pursuant to a non-discretionary, Issuer-mandated sell-to-cover arrangement, in order to cover tax withholding incident to the vesting of shares under the reporting person's restricted stock grant.
/s/ John Gebhart as attorney-in-fact for Edward Danse
2017-02-03